Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal Meningitis, Serogroup B”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Testing effectiveness (Phase 2)Study completedNCT00808028
What this trial is testing

A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents

Who this might be right for
Meningitis, Meningococcal
Pfizer 538
Early research (Phase 1)Study completedNCT00248833
What this trial is testing

Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis.

Who this might be right for
Meningitis, Meningococcal, Serogroup B
U.S. Army Medical Research and Development Command 34
Not applicableStudy completedNCT01452438
What this trial is testing

Safety Surveillance of MenACWY-CRM Vaccine in Children

Who this might be right for
Meningococcal Disease
Novartis Vaccines 393
Post-approval studies (Phase 4)Looking for participantsNCT06832514
What this trial is testing

Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons

Who this might be right for
Meningococcal Meningitis, Serogroup BTransgender PersonsSex Differences in Immune Response+1 more
University Ghent 250
Not applicableStudy completedNCT00161941
What this trial is testing

Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216

Who this might be right for
Meningococcal Meninigitis, Serogroup C
Pfizer 321
Post-approval studies (Phase 4)Active Not RecruitingNCT06113198
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 50
Post-approval studies (Phase 4)Study completedNCT01593514
What this trial is testing

Understanding the Immune Response to Two Different Meningitis Vaccines

Who this might be right for
MeningitisMeningococcal DiseaseSepticaemia
University of Oxford 20
Large-scale testing (Phase 3)Study completedNCT02305446
What this trial is testing

Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ.

Who this might be right for
Meningitis, Meningococcal, Serogroup B
Novartis 55
Post-approval studies (Phase 4)Study completedNCT02080559
What this trial is testing

Investigating the Immune Response to 4CMenB in Infants

Who this might be right for
Meningitis
University of Oxford 187
Not applicableStudy completedNCT01452464
What this trial is testing

Safety of MenACWY-CRM Vaccination in Adolescents

Who this might be right for
Meningococcal Disease
Novartis Vaccines 55,397
Testing effectiveness (Phase 2)Study completedNCT01461993
What this trial is testing

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Who this might be right for
VaccinesMeningococcal Vaccines
Pfizer 2,499
Large-scale testing (Phase 3)Study completedNCT01352793
What this trial is testing

A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years

Who this might be right for
Meningitis, Meningococcal
Pfizer 5,715
Testing effectiveness (Phase 2)Study completedNCT02946385
What this trial is testing

Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 604
Testing effectiveness (Phase 2)Study completedNCT01768117
What this trial is testing

Study To Describe The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine In Laboratory Workers ≥18 To ≤65 Years Of Age

Who this might be right for
Meningitis, Meningococcal, Serogroup B
Pfizer 13
Large-scale testing (Phase 3)Study completedNCT00901940
What this trial is testing

Understanding the Immune Response to Meningitis Vaccines

Who this might be right for
MeningitisSepticemia
University of Oxford 150
Testing effectiveness (Phase 2)Study completedNCT00962624
What this trial is testing

Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults

Who this might be right for
Meningococcal Meningitis, Serogroup AMeningococcal Meningitis, Serogroup BMeningococcal Meningitis, Serogroup C+2 more
Prof. Elizabeth Miller 38
Large-scale testing (Phase 3)Study completedNCT00657709
What this trial is testing

Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

Who this might be right for
Serogroup B Meningococcal Meningitis
Novartis Vaccines 3,630
Testing effectiveness (Phase 2)Study completedNCT01323270
What this trial is testing

A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years.

Who this might be right for
Meningococcal VaccinerLP2086Repevax+2 more
Pfizer 753
Testing effectiveness (Phase 2)Study completedNCT01461980
What this trial is testing

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Who this might be right for
VaccinesMeningococcal Vaccines
Pfizer 2,648
Large-scale testing (Phase 3)Study completedNCT00161928
What this trial is testing

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

Who this might be right for
Meningitis, Meningococcal
Pfizer 330
Next Page